- Is peritoneal carcinomatosis still the completely hopeless diagnosis?Publication without faculty affiliation
- Peritoneal carcinomatosis - Hopeless diagnosis?Publication without faculty affiliation
- HIPEC for peritoneal carcinomatosis are we able to calculate the appropriate dose of cytostatics?Publication without faculty affiliation
- Peritoneal carcinomatosis of colorectal origin treated by cytoreductive surgery and hyperthermic intraoperative peritoneal chemotherapy at the Bulovka University Hospital2021 | First Faculty of Medicine
- Peritoneal Carcinomatosis of Gastric Origin - Treatment Possibilities2019 | First Faculty of Medicine
- Peritoneal Carcinomatosis: Is there a chance for patientsPublication without faculty affiliation
- Peritoneal carcinomatosis in gastric cancer2023 | First Faculty of Medicine
- Hypertermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis2003 | First Faculty of Medicine
- Hypertermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis2003 | Faculty of Physical Education and Sport
- PIPAC - overview of the method and first use in the Czech Republic2020 | First Faculty of Medicine
- Peritoneal surface malignancy spread - reoperations after cytoreductive surgery + HIPEC2021 | First Faculty of Medicine
- Pilot study of Flt3 Ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas2003 | Faculty of Medicine in Hradec Králové
- HIPEC and other locoregional methods in clinical practicePublication without faculty affiliation
- Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis2000 | Faculty of Medicine in Hradec Králové
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours2021 | First Faculty of Medicine
- Malignant ascites - production can be influenced by means of HIPECPublication without faculty affiliation
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors2021 | First Faculty of Medicine
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors2021 | First Faculty of Medicine
- Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances2023 | Faculty of Medicine in Pilsen
- Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation2013 | First Faculty of Medicine
- Malignant Peritoneal Tumors - Introduction2019 | First Faculty of Medicine
- DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer2021 | Faculty of Medicine in Hradec Králové
- Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study)2022 | First Faculty of Medicine